You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

Details for Patent: 9,775,851


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,775,851 protect, and when does it expire?

Patent 9,775,851 protects SERNIVO and is included in one NDA.

This patent has six patent family members in four countries.

Summary for Patent: 9,775,851
Title:Topical formulations comprising a steroid
Abstract: The application provides formulations for the topical administration of an active agent comprising at least one steroid, in the form of topical sprays that are propellant-free, and/or substantially non-foaming, and/or alcohol-free. The present application also provides processes for preparing such compositions and methods of using them in management of skin diseases or disorders such as psoriasis, dermatoses, and other associated skin diseases or disorders.
Inventor(s): Ubaidulla; Udhumansha (Namakkal, IN), Kandavilli; Sateesh (Plainsboro, NJ), Vairale; Ajay Sunil (Hyderabad, IN), Wayne; Jeffrey A. (Markham, CA), Nalamothu; Vijendra (Basking Ridge, NJ), Meghal; Mistry (Ahmedabad, IN), Pakunlu; Refika Isil (Highland Park, NJ)
Assignee: Dr. Reddy's Laboratories, Ltd. (Hyderabad, Telangana, IN)
Application Number:15/495,148
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,775,851
Patent Claim Types:
see list of patent claims
Use; Composition; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,775,851

To delve into the specifics of the United States Patent 9,775,851, it is crucial to analyze several key aspects, including the patent's claims, scope, and the broader patent landscape. Here is a detailed breakdown of these elements.

Patent Overview

United States Patent 9,775,851, like any other patent, is a grant of a property right by the U.S. government to the inventor(s) or assignee(s) of the invention. This patent is issued by the U.S. Patent and Trademark Office (USPTO)[2].

Claims Analysis

Claim Structure

The claims of a patent define the scope of the invention and are crucial for determining what is protected by the patent. Claims can be independent or dependent. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[4].

Claim Language and Scope

The language used in the claims is critical. It must be clear and specific enough to define the invention but broad enough to cover the full scope of the inventor's contribution. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Patent Scope

Metrics for Measuring Scope

Patent scope can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims. Broader claims may face more scrutiny during the examination process and are less likely to be granted quickly[3].

Impact on Innovation

The scope of a patent can significantly impact innovation. Overly broad patents can lead to increased licensing and litigation costs, potentially diminishing incentives for further innovation. Therefore, the scope of the claims in Patent 9,775,851 must be carefully evaluated to ensure it does not stifle future developments in the field[3].

Patentability Requirements

For a patent to be granted, the invention must meet several requirements:

  • Utility: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior art.
  • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made[4].

Inventorship and Ownership

Correctly determining the true and only inventors is essential. US patent law requires that the inventors listed on the patent application are those who conceived the idea and reduced it to practice. Incorrect or incomplete identification of inventors can lead to challenges to the patent's enforceability[5].

Patent Term and Adjustments

The term of a patent can be adjusted due to delays in the prosecution process. Patent Term Adjustment (PTA) is granted if the USPTO fails to meet certain response times, extending the patent term accordingly. However, obviousness-type double patenting (ODP) analyses and terminal disclaimers must be considered in relation to these adjustments to prevent extending the patent term beyond what is legally permissible[1].

Obviousness-Type Double Patenting (ODP)

ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to PTA. This is crucial in ensuring that the patent system does not allow for the extension of patent terms through multiple related patents[1].

Examination Process

The examination process at the USPTO involves a thorough review of the patent application to ensure it meets all the requirements for patentability. The process tends to narrow the scope of patent claims, making them more specific and less broad. This narrowing is more significant when the examination duration is longer[3].

Forward Citations and Patent Maintenance

The number of forward citations (citations by later patents) and patent maintenance payments can also indicate the scope and impact of a patent. Patents with narrower claims tend to have more forward citations and higher maintenance payments, suggesting their importance and relevance in the field[3].

Broader Patent Landscape

Understanding the broader patent landscape involves looking at related patents, prior art, and the overall innovation trends in the field. This helps in assessing the novelty and nonobviousness of the invention and in predicting potential challenges or opportunities for the patent[4].

Key Takeaways

  • Claims and Scope: The claims of Patent 9,775,851 must be carefully analyzed to understand the protected invention and its scope.
  • Patentability Requirements: The invention must meet utility, novelty, and nonobviousness requirements.
  • Inventorship: Correct identification of inventors is crucial for the patent's enforceability.
  • Patent Term Adjustments: PTA and ODP analyses are important in determining the patent term.
  • Examination Process: The examination process narrows the scope of claims, ensuring specificity and clarity.
  • Broader Landscape: Understanding related patents and trends is essential for assessing the patent's impact.

Frequently Asked Questions

Q: What are the key requirements for a patent to be granted in the United States?

A: A patent must meet the requirements of utility, novelty, and nonobviousness, and the claims must define patentable subject matter[4].

Q: How is the scope of a patent measured?

A: The scope can be measured using metrics such as independent claim length and independent claim count[3].

Q: What is the significance of inventorship in patent law?

A: Correctly identifying the true and only inventors is essential for the patent's enforceability and to avoid future challenges[5].

Q: How does Patent Term Adjustment (PTA) affect the term of a patent?

A: PTA extends the patent term if the USPTO delays in responding during the prosecution process, but it must be considered in relation to ODP and terminal disclaimers[1].

Q: What is the role of the USPTO in the patent process?

A: The USPTO is responsible for granting U.S. patents and registering trademarks, and it ensures that patents meet all the necessary requirements for grant[2].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,775,851

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Primus Pharms SERNIVO betamethasone dipropionate SPRAY;TOPICAL 208079-001 Feb 5, 2016 RX Yes Yes 9,775,851 ⤷  Subscribe Y TREATMENT OF PLAQUE PSORIASIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,775,851

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
India2111/CHE/2009Aug 31, 2009

International Family Members for US Patent 9,775,851

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 2473161 ⤷  Subscribe
European Patent Office 2473161 ⤷  Subscribe
European Patent Office 3141246 ⤷  Subscribe
Japan 2013503203 ⤷  Subscribe
Japan 5833007 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2011026076 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.